NetworkNewsBreaks – Ethema Health Corp.’s (GRST) Seastone Facility Offers Range of Specialized Addiction Treatment Programs

Seastone of Delray – Drug Rehabilitation and Alcohol Treatment Center, owned and operated by Ethema Health Corporation (OTCQB: GRST) (formerly GreeneStone Healthcare Corporation), may be one of many substance abuse recovery and treatment facilities in Florida, but it stands out from the crowd due to the highly efficient individualized treatment options offered. Seastone is distinguished by a broad range of treatment programs – offered at varying intensities depending on the needs of the individual client – and careful attention paid to the individual client and family, ensuring a highly detailed assessment is conducted prior to the creation of a specialized treatment plan. “With a focus on customized treatment plans designed to help clients overcome their substance abuse issues permanently, Ethema Health Corporation’s center provides two forms of outpatient treatment: an intensive outpatient program, and a partial hospitalization program. Both approaches are built around the concepts of cognitive behavioral therapy and peer support, aiming to help clients see themselves and the world more clearly, and realize and accept that they’re facing an addiction issue, ultimately developing their stress management skills and self-esteem for long-term success.”

To view the full article, visit http://nnw.fm/e4uA9

About Ethema Health Corporation

Ethema Health Corporation (OTCQB: GRST), formerly GreeneStone Healthcare, through its subsidiaries offers addiction and mental health rehabilitation treatments for residents. Ethema Health Corporation has developed a unique style of treatment that has demonstrated much success with in-patient treatment for adults. The company will continue to develop its programs with its expansion into the United States. The company’s U.S.-based treatment center is located in Delray Beach, Florida, located between Palm Beach and Miami. For more information, visit www.seastonedrugrehab.com

About NetworkNewsBreaks

NetworkNewsBreaks (NNB) provide a rapid summary of corporate news that caught the attention of NetworkNewsWire (NNW). NNB keeps you up-to-date on active US Public Companies complementary to NNW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsBreaks – Bollente Companies, Inc. (BOLC) Stands Out as ‘One to Watch’

Bollente Companies (OTC: BOLC) is developing a diverse portfolio of companies, specifically targeting disruptive technologies with the potential to positively impact the environment and emerging economies. The company’s current focus is on high-efficiency electric tankless water heaters manufactured and sold under Bollente’s “trutankless” division, including a line of economy tankless water heaters sold under the Vero name. “By maintaining 99 percent efficiency, Bollente’s trutankless heaters use less energy than tank heaters, while providing the convenience of always-hot water. The system only uses power when there is demand, producing water to exact temperature, within one degree, even with sudden changes to input. Wireless apps allow for remote settings, notifications, and monitoring, and models are compatible with existing home automation and energy management systems. The technology also reduces size, for easy location, and the system’s self-flushing design provides up to 20+ years of maintenance free operation, significantly reducing upkeep and replacement costs. This becomes an additional environmental benefit since roughly 8 million used water heaters are dumped in landfills every year.”

To view the full article, visit http://nnw.fm/0J6wj

About Bollente Companies, Inc.

Founded in 2010, trutankless, a division of Bollente Companies, Inc. (OTC: BOLC) is in the early stages of developing a diverse portfolio of companies, targeting disruptive technologies that positively impact the environment and emerging economies. Founded in 2010, trutankless, a division of the company, was brought to life through the combined insight, ingenuity, and drive of industry professionals, engineers, and entrepreneurs. The objective was to create a line of electric tankless water heaters that far surpasses traditional tank water heaters in energy efficiency, output, dependability and environmental sustainability while overcoming the frustrating drawbacks of other tankless units on the market today. The trutankless mission is to efficiently provide hot water on demand by combining smart engineering with forward-thinking technologies that save owners money, energy, and space. For more information, please visit www.trutankless.com.

About NetworkNewsBreaks

NetworkNewsBreaks (NNB) provide a rapid summary of corporate news that caught the attention of NetworkNewsWire (NNW). NNB keeps you up-to-date on active US Public Companies complementary to NNW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsBreaks – Moxian, Inc. (NASDAQ: MOXC) Poised to Capitalize on China’s Changing Consumer Market

China’s economy is in the midst of a structural transition, and to capture the vast new opportunities within this changing consumer market, companies need to develop strategies that accommodate rapid shifts in the nature of consumption. “Despite a slowing economy, China will remain one of the fastest growing consumer markets in the world for the foreseeable future. Moxian, Inc. (NASDAQ: MOXC) is serving those businesses that are feeding the demands of the new Chinese consumer. Moxian provides small- and medium-sized businesses cutting edge turnkey solutions to attract and maintain customers. The company’s strategy is to drive consumer traffic from online to their brick and mortar business customers. Moxian operates a social network platform which integrates social media and business into a single platform and offers products, features and services that appeal to consumers.”

To view the full article, visit http://nnw.fm/l2IVy

About Moxian, Inc.

Founded in 2013 in Shenzhen, China with branch offices in Beijing, Malaysia, and Hong Kong, Moxian, Inc. is an offline-to-online (O2O) integrated platform operator. The company’s “Moxian+” mobile App platform connects users to merchant clients through games, rewards, and social events that they enjoy and in return, users provide valuable information that merchant clients can use to effectively promote products and services offered at their brick and mortar stores. More information about the company can be found at www.moxian.com.

About NetworkNewsBreaks

NetworkNewsBreaks (NNB) provide a rapid summary of corporate news that caught the attention of NetworkNewsWire (NNW). NNB keeps you up-to-date on active US Public Companies complementary to NNW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsBreaks – Aegis Capital Covers Inovio Pharmaceuticals, Inc. (NASDAQ: INO) with “Buy” Rating, $11 PT

Aegis Capital has issued a ‘Buy’ rating and price target of $11 on shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO). The analyst noted that Inovio is awaiting response from the FDA regarding the clinical hold on VGX-3100 phase 3, which is expected to be resolved this month. The company plans to initiate its phase 3 trial with VGX-3100 for HPV-related cervical dysplasia by the second half of 2017. The trial is expected to last approximately two years, with NDA submission in 2020 and product launch in 2021.

For more information, visit www.inovio.com

About Inovio Pharmaceuticals, Inc.

Inovio is taking immunotherapy to the next level in the fight against cancer and infectious diseases. The company is the only immunotherapy company that has reported generating T cells in vivo in high quantity that are fully functional and whose killing capacity correlates with relevant clinical outcomes with a favorable safety profile. With an expanding portfolio of immune therapies, the company is advancing a growing preclinical and clinical stage product pipeline. Partners and collaborators include MedImmune, Regeneron, The Wistar Institute, University of Pennsylvania, DARPA, GeneOne Life Science, Plumbline Life Sciences, ApolloBio Corporation, Drexel University, NIH, HIV Vaccines Trial Network, National Cancer Institute, U.S. Military HIV Research Program, and Laval University.

About NetworkNewsBreaks

NetworkNewsBreaks (NNB) provide a rapid summary of corporate news that caught the attention of NetworkNewsWire (NNW). NNB keeps you up-to-date on active US Public Companies complementary to NNW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsBreaks – Aegis Capital Reiterates “Buy” Rating on Concert Pharmaceuticals, Inc. (NASDAQ: CNCE)

Aegis Capital has reiterated a ‘Buy’ rating and price target of $25 on shares of Concert Pharmaceuticals, Inc. (NASDAQ: CNCE). The company recently said it has received notice from the FDA that its CTP-543 phase 2a clinical trial for alopecia areata has been placed on clinical hold. The FDA is requesting a review of non-clinical toxicology studies to evaluate the planned one-year dosing. Concert said it intends to submit a response shortly, which the FDA will review within 30 days. The analyst noted the hold and said he believes the issue will be easily resolved without a long delay in Concert’s clinical trial.

For more information, visit www.concertpharma.com

About Concert
Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel medicines designed to address unmet patient needs. The company’s approach starts with approved drugs in which deuterium substitution has the potential to enhance clinical safety, tolerability or efficacy. Concert has a broad pipeline of innovative medicines targeting pulmonary diseases, including cystic fibrosis, autoimmune and inflammatory diseases and central nervous systems (CNS) disorders.

About NetworkNewsBreaks

NetworkNewsBreaks (NNB) provide a rapid summary of corporate news that caught the attention of NetworkNewsWire (NNW). NNB keeps you up-to-date on active US Public Companies complementary to NNW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on May 18, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage:

ARQL 34.12% – News: Presenting at EHA Congress on June 23 in Madrid, Spain

TNTY 21.88% – News: Forms joint-venture subsidiary

MRMD 10.01% – News: Reports Q1 2017 revenue

OPXS 4.17% – News: Secures $2.16M supplier agreement

SIRI 4.02% – News: Launches new talk show with actress Anne Heche

QUMU 3.47% – News: Unveils Qx video platform

VSTM 3.12% – News: Presenting at EHA Congress on June 25

CASI 3.09% – News: Presenting at ASCO Annual Meeting June 2-6

FNJN 2.84% – News: Presenting at two upcoming conferences in California

TISA 2.68% – News: Posts Q1 2017 results

About NetworkNewsBreak

NetworkNewsBreaks (NNB) provide a rapid summary of corporate news that caught the attention of NetworkNewsWire (NNW). NNB keeps you up-to-date on active US Public Companies complementary to NNW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsBreaks – EnteroMedics, Inc. (NASDAQ: ETRM) Shares Surge on First vBloc® Neurometabolic Therapy Implant

EnteroMedics (NASDAQ: ETRM) shares are up 12% late-morning following news that the first implant of the company’s vBloc® Neurometabolic Therapy was successfully completed at the McGuire Veterans Affairs Medical Center (Richmond VAMC) in Richmond, Virginia, earlier this week. The pacemaker-like device works to control sensations of hunger to enable patients to control their appetite and lose weight. “With our first implant at the Richmond VAMC, we are making vBloc accessible to an even larger portion of the men and women who have served our country selflessly and are in need of solutions to address their obesity. Through our previously announced partnership with Academy Medical, eligible veterans are able to receive vBloc Therapy at little to no cost. We look forward to working with other VA medical centers and VA Choice facilities so they can offer this state-of-the art weight loss treatment,” EnteroMedics president, CEO and chairman of the board Dan Gladney stated in the news release.

To view the full press release, visit: http://nnw.fm/TBq4H

About EnteroMedics Inc.

EnteroMedics is a medical device company focused on the development and commercialization of its neuroscience based technology to treat obesity and metabolic diseases. vBloc® Neurometabolic Therapy, delivered by a pacemaker-like device called the vBloc® System, is designed to intermittently block the vagus nerves using high-frequency, low-energy, electrical impulses. EnteroMedics’ vBloc® System has received U.S. Food and Drug Administration approval and CE Mark. For additional prescribing information, please visit www.enteromedics.com.

About NetworkNewsBreak

NetworkNewsBreak (NNB) provides a rapid summary of corporate news that caught the attention of NetworkNewsWire (NNW). NNB keeps you up-to-date on active US Public Companies complementary to NNW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com